Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-010984
Filing Date
2022-03-08
Accepted
2022-03-07 21:53:35
Documents
53
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_biotechacq.htm   iXBRL 10-K 1118362
2 CODE OF ETHICS AND BUSINESS CONDUCT f10k2021ex14-1_biotechacq.htm EX-14.1 58587
3 CERTIFICATION f10k2021ex31-1_biotechacq.htm EX-31.1 13193
4 CERTIFICATION f10k2021ex31-2_biotechacq.htm EX-31.2 17374
5 CERTIFICATION f10k2021ex32-1_biotechacq.htm EX-32.1 6988
6 CERTIFICATION f10k2021ex32-2_biotechacq.htm EX-32.2 7136
  Complete submission text file 0001213900-22-010984.txt   4156208

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE biot-20211231.xsd EX-101.SCH 45203
8 XBRL CALCULATION FILE biot-20211231_cal.xml EX-101.CAL 21729
9 XBRL DEFINITION FILE biot-20211231_def.xml EX-101.DEF 185343
10 XBRL LABEL FILE biot-20211231_lab.xml EX-101.LAB 347107
11 XBRL PRESENTATION FILE biot-20211231_pre.xml EX-101.PRE 191678
47 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_biotechacq_htm.xml XML 381650
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39935 | Film No.: 22720200
SIC: 2834 Pharmaceutical Preparations